Trial at the Johns Hopkins Kimmel Cancer Center and other centers finds reduced-intensity haploidentical bone marrow transplant can cure sickle cell disease
The study finds that the mortality rate for pregnant people with sickle cell disease is 26 times higher than the national average—a figure that hasn't improved since the last time this population was assessed
As part of the university's Racism and Repair in the Modern Academy project, Johns Hopkins researchers look inward at the past, present, and future of treatment for this disease